Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

Clinical trial NCT00498992 · UNKNOWN

Trial details

NCT number: NCT00498992
Sponsor: Ingalls Memorial Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Dermatologic Complications Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.